Literature DB >> 18157397

Prevalence of intestinal microsporidiosis in human immunodeficiency virus-infected patients with diarrhea in major United States cities.

Mark S Dworkin1, Susan E Buskin, Arthur J Davidson, David L Cohn, Anne Morse, Jeffrey Inungu, Michael R Adams, Scott B McCombs, Jeffrey L Jones, Hercules Moura, Govinda Visvesvara, Norman J Pieniazek, Thomas R Navin.   

Abstract

To determine the prevalence of intestinal microsporidiosis in HIV-infected patients, we performed a prospective study of HIV-infected patients with diarrheal illnesses in three US hospitals and examined an observational database of HIV-infected patients in 10 US cities. Among 737 specimens from the three hospitals, results were positive for 11 (prevalence 1.5%); seven (64%) acquired HIV through male-to-male sexual contact, two (18%) through male-to-male sexual contact and injection drug use, and one (9%) through heterosexual contact; one (9%) had an undetermined mode of transmission. Median CD4 count within six months of diagnosis of microsporidiosis was 33 cells/microL (range 3 to 319 cells/microL). For the national observational database (n = 24,098), the overall prevalence of microsporidiosis was 0.16%. Prevalence of microsporidiosis among HIV-infected patients with diarrheal disease is low, and microsporidiosis is most often diagnosed in patients with very low CD4+ cell counts. Testing for microsporidia appears to be indicated, especially for patients with very low CD4+ cell counts.

Entities:  

Mesh:

Year:  2007        PMID: 18157397     DOI: 10.1590/s0036-46652007000600001

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.

Authors:  Anthony P Sinai; Edna S Kaneshiro; Honorine Ward; Louis M Weiss; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2011-12-09

2.  Unusual Enterocytozoon bieneusi genotypes and Cryptosporidium hominis subtypes in HIV-infected patients on highly active antiretroviral therapy.

Authors:  Frederick O Akinbo; Christopher E Okaka; Richard Omoregie; Haileeyesus Adamu; Lihua Xiao
Journal:  Am J Trop Med Hyg       Date:  2013-04-29       Impact factor: 2.345

3.  Emerging microsporidian infections in Russian HIV-infected patients.

Authors:  Olga I Sokolova; Anton V Demyanov; Lisa C Bowers; Elizabeth S Didier; Alexei V Yakovlev; Sergei O Skarlato; Yuliya Y Sokolova
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

Review 4.  Enteric protozoa in the developed world: a public health perspective.

Authors:  Stephanie M Fletcher; Damien Stark; John Harkness; John Ellis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

5.  Intestinal microsporidiosis among HIV/AIDS patients receiving antiretroviral therapy in Sana'a city, Yemen: first report on prevalence and predictors.

Authors:  Kwkab A R Al-Brhami; Rashad Abdul-Ghani; Salah A Al-Qobati
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

6.  Epidemiology, clinical, immune, and molecular profiles of microsporidiosis and cryptosporidiosis among HIV/AIDS patients.

Authors:  Roger Wumba; Benjamin Longo-Mbenza; Jean Menotti; Madone Mandina; Fabien Kintoki; Nani Hippolyte Situakibanza; Marie Kapepela Kakicha; Josue Zanga; Kennedy Mbanzulu-Makola; Tommy Nseka; Jean Pierre Mukendi; Eric Kendjo; Jean Sala; Marc Thellier
Journal:  Int J Gen Med       Date:  2012-07-19

7.  Zoonotic potential of Enterocytozoon bieneusi among children in rural communities in Thailand.

Authors:  Hirotake Mori; Aongart Mahittikorn; Dorn Watthanakulpanich; Chalit Komalamisra; Yaowalark Sukthana
Journal:  Parasite       Date:  2013-04-11       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.